New Methods and Models for the Isoniazid Acetylation Polymorphism

[1]  W. Weber,et al.  Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver. , 1978, Molecular pharmacology.

[2]  J. Oates,et al.  Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. , 1978, The New England journal of medicine.

[3]  J. Davidson,et al.  Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression. , 1978, The American journal of psychiatry.

[4]  C. Mcqueen,et al.  N-Acetylation of drugs. A genetically controlled reciprocal relationship between drug N-acetylating enzymes of rabbit liver and peripheral blood cells. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[5]  R. Larsson,et al.  Spontaneous systemic lupus erythematosus and acelylator phenotype. , 2009, Acta medica Scandinavica.

[6]  P. K. Lunde,et al.  Disease and Acetylation Polymorphism , 1977, Clinical pharmacokinetics.

[7]  E. Hess,et al.  Acetylator phenotype in systemic lupus erythematosus. , 1977, Arthritis and rheumatism.

[8]  E. Johnstone The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine , 1976, Psychopharmacologia.

[9]  S. Thorgeirsson,et al.  Genetic differences in 2-acetylaminofluorene mutagenicity in vitro associated with mouse hepatic aryl hydrocarbon hydroxylase activity induced by polycyclic aromatic compounds. , 1976, Molecular pharmacology.

[10]  U. Thorgeirsson,et al.  Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. , 1976, Annals of internal medicine.

[11]  J. H. Martin,et al.  The acetylator phenotype of patients with systemic lupus erythematosus. , 1974, Drug metabolism and disposition: the biological fate of chemicals.

[12]  G. Bryan,et al.  Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. , 1973, Biochemical pharmacology.

[13]  W. Weber ACETYLATION OF DRUGS , 1973 .

[14]  I. Mackay,et al.  Antinuclear antibody response to procainamide in man and laboratory animals. , 1972, American heart journal.

[15]  T. Feltkamp,et al.  Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA). , 1972, Clinical and experimental immunology.

[16]  E. Dubois,et al.  Failure of procainamide to induce a systemic lupus erythematosus-like disease in animals. , 1972, Toxicology and applied pharmacology.